CIK 0001812364
- Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale See remarks sold 80,909 shares at an average $4.27 ($345,572)
- 4 Open-market sale Chief Legal Officer sold 299 shares at $4.38 ($1,310)
- 4 Open-market sale President, R&D sold 657 shares at $4.38 ($2,878)
- 4 Planned sale Chief Financial Officer sold 4,865 shares at an average $4.42 ($21,491)
- 4 Open-market sale See remarks sold 400 shares at $4.38 ($1,752)
- 4 Planned sale President and CEO sold 100,000 shares at $5.00 ($500,000)
- 4 Open-market sale See remarks sold 1,621 shares at $6.06 ($9,823)
- 4 Planned sale Chief Financial Officer sold 9,102 shares at an average $6.03 ($54,905)
- 4 Open-market sale President, R&D sold 2,688 shares at $6.06 ($16,289)
- 4 Open-market sale Chief Legal Officer sold 1,632 shares at $6.06 ($9,890)
- 4 Open-market sale See remarks sold 245 shares at $7.51 ($1,840)
- 4 Planned sale Chief Financial Officer sold 6,457 shares at an average $7.46 ($48,184)
- 4 Open-market sale President, R&D sold 648 shares at $7.51 ($4,866)
- 4 Open-market sale Chief Legal Officer sold 295 shares at $7.51 ($2,215)
- 4 Planned sale Chief Financial Officer sold 10,780 shares at an average $8.56 ($92,316)
Page 5 of 16 · 320 filings